Development of copy number assays for detection and surveillance of piperaquine resistance associated plasmepsin 2/3 copy number variation in Plasmodium falciparum

BACKGROUND: Long regarded as an epicenter of drug-resistant malaria, Southeast Asia continues to provide new challenges to the control of Plasmodium falciparum malaria. Recently, resistance to the artemisinin combination therapy partner drug piperaquine has been observed in multiple locations across...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Malar J
Asıl Yazarlar: Ansbro, Megan R., Jacob, Christopher G., Amato, Roberto, Kekre, Mihir, Amaratunga, Chanaki, Sreng, Sokunthea, Suon, Seila, Miotto, Olivo, Fairhurst, Rick M., Wellems, Thomas E., Kwiatkowski, Dominic P.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2020
Konular:
Methodology
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7218657/
https://ncbi.nlm.nih.gov/pubmed/32404110
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12936-020-03249-x
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller